OncoMatch/Clinical Trials/NCT06468254

An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer

Is NCT06468254 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including Statin and Sugar pill for ovarian cancer.

Phase 2RecruitingAnhui Provincial Cancer HospitalNCT06468254Data as of May 2026

Treatment: Statin · Sugar pill — This study aims to evaluate the effect of statins combined with conventional chemotherapy and maintenance therapy on the prognosis of ovarian cancer patients, exploring its potential to improve survival rates and quality of life.

Check if I qualify

Extracted eligibility criteria

Cancer type

Ovarian Cancer

Lab requirements

Kidney function

Serum creatinine ≤1.5x ULN, or creatinine clearance rate ≥60 mL/min (Cockcroft-Gault formula)

Liver function

Total bilirubin ≤1.5x ULN or direct bilirubin ≤1.0x ULN; AST/ALT ≤2.5x ULN (≤5x ULN with liver metastases)

Liver Function: Total bilirubin ≤1.5x ULN or direct bilirubin ≤1.0x ULN; AST/ALT ≤2.5x ULN (≤5x ULN with liver metastases). Kidney Function: Serum creatinine ≤1.5x ULN, or creatinine clearance rate ≥60 mL/min (Cockcroft-Gault formula).

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify